Incyte Corp
NASDAQ:INCY
Incyte Corp
Total Other Income
Incyte Corp
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Incyte Corp
NASDAQ:INCY
|
Total Other Income
$184.3m
|
CAGR 3-Years
181%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$3.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-78%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$158m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$55.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Incyte Corp's Total Other Income?
Total Other Income
184.3m
USD
Based on the financial report for Mar 31, 2024, Incyte Corp's Total Other Income amounts to 184.3m USD.
What is Incyte Corp's Total Other Income growth rate?
Total Other Income CAGR 5Y
47%
Over the last year, the Total Other Income growth was 158%. The average annual Total Other Income growth rates for Incyte Corp have been 181% over the past three years , 47% over the past five years .